FIELD: organic chemistry, biochemistry, pharmacy. SUBSTANCE: invention describes a compound of the formula (I) or its pharmaceutically acceptable salt where: X-Y-Z is taken from the group involving: (a) -C(O)-CH2CH2-; (b) -C(O)-O-CR5(R5′); (c) -S-N=CH-; (d) -CH=N-S- when (b) means a double bond and (a) and (c) mean simple bonds; and X-Y-Z means the group = N-S-CH= when (a) and (c) mean double bonds and (b) means a simple bond; and R1 is taken from the group involving: (a) S(O)2CH3; (b) S(O)2NH2; (c) S(O)2NHC(O)CF3; R2 is taken from the group involving: (a) C3,C4,C5,C6,C7-cycloalkyl; (b) mono-, di- or trisubstituted phenyl where substitutes are taken from the group involving: (1) hydrogen atom; (2) halogen atom; (3) C1-6-alkoxy-group; (4) C1-6-alkylthio-group; (5) CO2H; R5 and R6 each independently is taken from the group involving: (a) hydrogen atom; (b) C1-6-alkyl. Invention describes also a method of synthesis the above indicated compounds, a method of patients treatment and a pharmaceutical composition based on compounds of the formula (I) which is used for treatment of patients with an cyclooxygenase-mediated inflammatory disease. EFFECT: improved method of synthesis, anti-inflammatory effect. 24 cl, 4 tbl, 56 ex
Title |
Year |
Author |
Number |
DIARYL-5,6-CONDENSED HETEROCYCLIC ACIDS, PHARMACEUTICAL COMPOSITION, AND METHOD OF PROTECTION FROM EFFECTS OF LEUKOTRIENES |
1993 |
- Robert N.Jang
- Mark Label'
- Iv Leblan
- Ji Bin Ksjang
- Cheuk L.Lau
- Klod Djufren
- Iv Garo
|
RU2154065C2 |
PYRIDOPYRROLIZINE AND PYRIDOINDOLIZINE DERIVATIVES |
2003 |
- Leblan Iv
- Djufren Klod
- Roj Patrik
|
RU2342386C2 |
CATHEPSIN-CYSTEINE PROTEASE INHIBITORS |
2003 |
- Behjli Kristofer I.
- Blehk Kehmeron
- Lezhe Serzh
- Li Chun Sing
- Makkehj Dehn
- Mellon Kristof
- Got'E Zhak Iv
- Lau Cheuk
- Ter'En Mishel'
- Truong Vouj-Linkh
- Grin Majkl Dzh.
- Khirshbejn Bernard L.
- Dzhehnk Dzhejms U.
- Palmer Dzhejms T.
- Baskaran Chitra
|
RU2312861C2 |
DERIVATIVES OF QUINOLINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF SHOWING ACTIVITY OF LEUKOTRIENE ANTAGONIST |
1993 |
- Robert Zamboni
- Dehniehl Guehj
- Mark Labell'
|
RU2143426C1 |
METHOD OF PREPARING PHENYL HETEROCYCLES, AND INTERMEDIATE COMPOUND |
1995 |
- Richard Dezmond
- Ul'F Dolling
- Ben Mehrk'Jun
- Richard Tillajer
- Dehvid Chehn
|
RU2160257C2 |
CYSTEIC CATHEPSIN PROTEASE INHIBITOR |
2005 |
- Got'E Zhak Iv
- Li Chun' Sing
- Mellon Kristof
|
RU2399613C2 |
4-OXO-1-(3-SUBSTITUTED PHENYL)-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDES, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, METHOD FOR TREATMENT AND PROPHYLAXIS AND METHOD FOR IMPROVING COGNITIVE ABILITY IN HEALTH SUBJECT |
2003 |
- Djub Daniel'
- Gallan Mishel'
- Ljakomb Patrik
- Aspiotis Rene
- Djub Lorans
- Zhirar Iv
- Makdonal'D Duajt
|
RU2312865C2 |
SUBSTITUTED MORPHOLINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF COUNTERACTION TO SUBSTANCE P OR INHIBITION OF NEUROKININ-1 RECEPTORS |
1995 |
- Konrad P. Dorn
- Dzheffri Dzh. Khejl
- Mal'Kol'M Makkoss
- Sander G. Mills
|
RU2170233C2 |
SUBSTITUTED MORPHOLINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF DECREASE OF TACHIKININ LEVEL IN TREATMENT OR PROPHYLAXIS OF PHYSIOLOGICAL STATES ASSOCIATED WITH TACHIKININ EXCESS |
1994 |
- Rejmond Bejker
- Timoti Kharrison
- Angus Mjurrej Makled
- Ehndrju Pehjt Ouvens
- Ehjlin Mehri S'Juard
- Kristofer Dzhon Svejn
- Martin Richard Till
|
RU2131426C1 |
SPIROPIPERIDINES, METHODS OF THEIR SYNTHESIS (VARIANTS) |
1993 |
- Meng-Khsin Chen
- Dehvid B. R. Dzhonston
- Rehvi P. Nargund
- Artur A. Patchett
- Dzhehjms R. Tata
- Likhu Jang
|
RU2168512C2 |